Results 41 to 50 of about 13,680 (210)

Evaluation of Clinical Characteristics and Treatment Outcomes of Graves Disease in Children and Adolescents

open access: yesTrends in Pediatrics, 2021
Objective: The most common cause of hyperthyroidism in childhood and adolescence is Graves’ disease. In this study, we aimed to evaluate the demographic characteristics, clinical and laboratory findings, treatment processes, and remission outcomes in ...
Alev Aldemir Sönmez   +5 more
doaj   +1 more source

Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study [PDF]

open access: yes, 2007
In most trials, at least 30-60% of patients with Graves' disease treated with antithyroid drugs relapse within 2 years after therapy withdrawal. At present, there are no prognostic parameters available early in treatment to indicate patients likely to ...
AGABITI ROSEI E   +8 more
core   +1 more source

Flavin-containing monooxygenases: mutations, disease and drug response [PDF]

open access: yes, 2008
NOTICE: this is the author’s version of a work that was accepted for publication in Trends in Pharmacological Sciences. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality ...
Phillips, IR, Shephard, EA
core   +1 more source

Assessment of bone marrow-derived mesenchymal stem cells capacity for odontogenic differentiation and dentin regeneration in methimazole-treated albino rats (Light microscopic Study)

open access: yesSaudi Dental Journal, 2022
Background: Methimazole is an antithyroid drug. It has side effects on many tissues. Bone marrow-derived mesenchymal stem cells (BM-MSCs) are promising in the field of tissue regeneration.
Amany A. Rabea
doaj   +1 more source

A Devastating Storm [PDF]

open access: yes, 2013
Case Report A 26-year-old female with no significant medical history presented with palpitations and shortness of breath. Two weeks prior, she experienced rhinorrhea and congestion.Vital signs on admission were temperature 96.6°F, heart rate 252 beats ...
Merrill, MD, Eve
core   +2 more sources

Stroke Mimic: A Case of Unilateral Thyrotoxic Hypokalemic Periodic Paralysis [PDF]

open access: yes, 2020
Thyrotoxic hypokalemic periodic paralysis (THPP) is a condition that results in transient skeletal muscle paralysis secondary to intracellular potassium sequestration.
Lajeunesse, Michael, Young, Scott
core  

Drug metabolism by flavin-containing monooxygenases of human and mouse [PDF]

open access: yes, 2016
Introduction: Flavin-containing monooxygenases (FMOs) play an important role in drug metabolism. / Areas covered: We focus on the role of FMOs in the metabolism of drugs in human and mouse.
Phillips, IR, Shephard, EA
core   +1 more source

Introducing the Cis‐2,3‐Bis(trifluoromethyl)cyclopropyl Chemotype: Late‐Stage Installation and Stereoelectronic Properties

open access: yesChemistryEurope, Volume 4, Issue 2, February 2026.
The cis‐2,3‐bis(trifluoromethyl)cyclopropyl chemotype is introduced. The steric demand of this motif is intermediate between that of the heptafluoroisopropyl and prefluorotertbutyl groups; yet, it induces significantly less lipophilicity than these due to its facial polarity.
Daniel Gaviña   +5 more
wiley   +1 more source

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use

open access: yesCase Reports in Endocrinology, 2015
ANCA-associated vasculitis (AAV) is a rare and potentially life threatening complication associated with antithyroid drug use. It is more commonly reported with propylthiouracil, with fewer cases reported with methimazole use. We present the case of a 55-
Deep Shikha   +3 more
doaj   +1 more source

Role of thyroid hormones in early postnatal development of skeletal muscle and its implications for undernutrition [PDF]

open access: yes, 1996
Published online by Cambridge University Press 09 Mar 2007Energy intake profoundly influences many endocrine axes which in turn play a central role in development.
A. P. Harrison   +19 more
core   +2 more sources

Home - About - Disclaimer - Privacy